How are chronic rhinosinusitis and gastro‑oesophageal reflux disease related, and should patients with chronic rhinosinusitis be screened and treated for GERD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Association Between Chronic Rhinosinusitis and Acid Reflux

While there is evidence suggesting an association between GERD and chronic rhinosinusitis, the relationship remains unclear with weak evidence, and routine screening or empiric treatment of GERD is not recommended for all CRS patients based on current guidelines.

The Evidence for Association

The 2020 European Position Paper on Rhinosinusitis 1 acknowledges that some evidence demonstrates an association between gastro-oesophageal reflux disease (GORD) and CRS. CRS patients have been shown to have significantly higher incidences of gastro-oesophageal reflux compared with asymptomatic controls, and CRS is more prevalent in GORD sufferers than those without GORD. However, the guideline explicitly states that while GERD may play a role in CRS in at least some patients, CRS is a multifactorial process.

Recent Mendelian randomization studies provide stronger genetic evidence:

  • A 2024 study 2 found that GERD increased the risk of developing CRS by 36% (OR 1.360,95% CI 1.179-1.568, P < 0.001)
  • Another 2024 bidirectional study 3 confirmed GERD was associated with increased risk of CRS (OR: 1.36,95% CI: 1.18-1.57, p < 0.001)
  • A 2024 meta-analysis 4 showed significant association between GERD and CRS (P < .001; CI 3.56 [2.25,5.65])

What the Guidelines Actually Recommend

The American Academy of Otolaryngology 2015 guidelines 5 do not include GERD screening or treatment as a key action statement for CRS management. The guideline notes that the relationship between GERD and rhinosinusitis is unclear, with high-level evidence lacking. Most supporting studies are small case series. The guideline states that patients with clinically significant GERD should be managed accordingly, but whether treating mild or subclinical GERD can affect rhinosinusitis is unknown.

The 2005 practice parameter 6 provides more specific guidance: pH probe monitoring of both children and adults with chronic sinusitis shows a high incidence of both esophageal and nasopharyngeal reflux, and medical treatment of GERD has been shown to result in significant improvement in sinusitis symptoms. In patients with sinusitis refractory to medical therapy, treatment of associated GERD should be considered before surgical intervention.

Clinical Approach

When to Consider GERD in CRS Patients:

  1. Refractory CRS: Patients who have failed standard CRS therapy (saline irrigation, topical intranasal corticosteroids) 5

  2. Presence of GERD symptoms: Patients with prominent upper GI symptoms consistent with GERD 7

  3. Pre-surgical evaluation: Before considering sinus surgery in treatment-resistant cases 6

Diagnostic Considerations:

The 2023 AGA guidelines 8 emphasize that there is no single diagnostic tool that can conclusively identify GER as the cause of extraesophageal symptoms. Determination should be based on global clinical impression derived from symptoms, response to GER therapy, and results of endoscopy and reflux testing.

For CRS patients with suspected GERD contribution:

  • Normal esophagoscopy does not rule out GERD as a contributing factor 7
  • 24-hour esophageal pH monitoring may be considered, though its role in CRS is not well-established
  • Empiric PPI therapy can be considered in appropriate patients

Treatment Evidence:

The 2024 meta-analysis 4 found that 93% of CRS patients showed improvement on PPIs, and all studies evaluating PPI therapy in CRS patients reported positive outcomes. However, only one double-blind placebo-controlled trial has evaluated proton-pump inhibitors in CRS 1.

Common Pitfalls to Avoid:

  1. Do not routinely screen all CRS patients for GERD - The evidence does not support universal screening
  2. Do not assume GERD is the primary cause - CRS is multifactorial; GERD may be one contributing factor among many
  3. Do not delay standard CRS treatment - First-line therapy remains saline irrigation and topical intranasal corticosteroids 5
  4. Do not overlook other modifying factors - Assess for asthma, immunodeficiency, ciliary dyskinesia, and allergies 5

Practical Algorithm:

For newly diagnosed CRS:

  • Initiate standard therapy (saline irrigation, intranasal corticosteroids)
  • Do not routinely evaluate or treat for GERD

For refractory CRS (failed 3+ months of standard therapy):

  • Assess for GERD symptoms (heartburn, regurgitation, throat clearing)
  • If GERD symptoms present: Consider empiric PPI trial for 3 months
  • If no GERD symptoms but truly refractory: May consider pH monitoring before surgical intervention 6

The key distinction is that GERD evaluation and treatment should be reserved for patients with refractory CRS or those with coexisting GERD symptoms, not as routine practice for all CRS patients.

References

Research

Causal analysis between gastroesophageal reflux disease and chronic rhinosinusitis.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024

Guideline

clinical practice guideline (update): adult sinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Guideline

the diagnosis and management of sinusitis: a practice parameter update.

Journal of Allergy and Clinical Immunology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.